Invention Grant
- Patent Title: Mutated immunoglobulin-binding polypeptides
-
Application No.: US15525688Application Date: 2015-11-11
-
Publication No.: US11566082B2Publication Date: 2023-01-31
- Inventor: Gustav Rodrigo , Tomas Bjorkman , Mats Ander
- Applicant: Cytiva BioProcess R&D AB
- Applicant Address: SE Uppsala
- Assignee: Cytiva BioProcess R&D AB
- Current Assignee: Cytiva BioProcess R&D AB
- Current Assignee Address: SE Uppsala
- Agency: Eversheds Sutherland (US) LLP
- Priority: SE1451376-6 20141117,GB1510261 20150612,GB1510263 20150612
- International Application: PCT/EP2015/076642 WO 20151111
- International Announcement: WO2016/079034 WO 20160526
- Main IPC: C07K16/46
- IPC: C07K16/46 ; B01D15/38 ; B01J20/289 ; B01J20/32 ; C07K1/22 ; C07K14/31 ; C07K16/00 ; C07K16/06

Abstract:
An Fc-binding polypeptide of improved alkali stability, comprising a mutant of an Fc-binding domain of Staphylococcus Protein A (SpA), as defined by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO 26 or SEQ ID NO 27, wherein at least the alanine residue at the position corresponding to position 42 in SEQ ID NO:4-7 has been mutated to arginine and/or wherein at least the aspartic acid residue at the position corresponding to position 37 in SEQ ID NO:4-7 has been mutated to glutamic acid.
Public/Granted literature
- US10954309B2 Mutated immunoglobulin-binding polypeptides Public/Granted day:2021-03-23
Information query